戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ed by Western blot with pooled or individual sera.
2 ed by ADCC mediated by HIV-positive (HIV(+)) sera.
3 mbination with other epitopes, using patient sera.
4 g H7N9 and H5N1, have been detected in human sera.
5 ors by 3T3-L1 adipocytes as well as in human sera.
6 ca was 33% (14/43) from the available stored sera.
7  circulating EDA in cord blood than in adult sera.
8 p15 and/or Cp23 antigens between consecutive sera.
9 s was observed between pre- and postpandemic sera.
10 ry enriched by panning on the pool of cancer sera.
11 rocessed foods and the reactivity to patient sera.
12 nspecific background binding in CCD-positive sera.
13 lood group O allogeneic RBC in 22% of tested sera.
14 x antibodies were found in 162 of 1131 (14%) sera.
15 or GI.1 infection, as measured from archived sera.
16 0% and the other proteins with <33.3% of the sera.
17 he secretion of specific antibodies into the sera.
18 sed to evaluate immunoreactivity using human sera.
19 stress accompanied by lowered cholesterol in sera.
20 mal fusion was observed with postvaccination sera.
21 nosa BSI; 56 cases were accompanied by acute sera.
22 om ADCC-mediating antibodies present in HIV+ sera.
23 V4 to neutralization by DENV3 primary immune sera.
24 ells to ADCC mediated by HIV-positive (HIV+) sera.
25 IV-1-infected cells to ADCC mediated by HIV+ sera.
26          Of the remaining 72 double-negative sera, 10 (14%) immunoprecipitated (125)I-alphaDTX itself
27 and in detecting stage II and III LD patient sera (100% and 100% sensitivity).
28            IgE reactivity of 10 CCD-positive sera (14.0-52.5 kUA/L) with the recombinant allergens rP
29 h peach leaf extract revealed in six patient sera a pair of bands of 10 and 16 kDa, and in nine a 16-
30 atography, we obtained from HCV-seronegative sera a purified fraction enriched in inhibitory factors.
31 the broadest reactivity with myeloma patient sera after allogeneic HSCT and that may be significantly
32       The findings suggest that convalescent sera alone is not sufficient for providing 100% protecti
33                                   Chimpanzee sera also showed robust neutralizing activity against RA
34     GT, but not bmGT, was detected in 71% of sera and 50% of BALF of neutropenic mice; neither was de
35  kidney extracts by immunoblot using patient sera and an anti-alpha-Gal antibody.
36 tibodies have since been isolated from human sera and associated with positive and negative outcomes
37 lyzed by collecting draining lymph nodes and sera and by challenging the animals.
38 ication of favorable donors with potent bnAb sera and by development of improved methods for human an
39 oduct FFA]/[precursor FFA] ratios in fasting sera and clinical data from 481 individuals who particip
40  immunoassay analysis with rabbit polyclonal sera and human IgE indicated only minor differences in p
41 ng unit were used to screen human and rabbit sera and identify epitope hits.
42 ndpoint titers and avidity indices of IgG in sera and IgA in tracheal, lung, and intestinal secretion
43 emained higher with IgHPolyFab in the normal sera and in IVIg, but the reverse was true when the auto
44 P) activities, were present with both immune sera and isolated MAbs, confirming the induction of nonn
45                            In addition, both sera and mAbs from the dengue-infected patients enhanced
46            In the current study, both immune sera and monoclonal antibodies from vaccinated humans sh
47 horesis SDS-PAGE-immunoblotting with patient sera and rabbit serum anti-Pru p 3.
48 red HLA (r = 0.40) and highest using diluted sera and SAB with 30% or less denatured HLA (r = 0.86).
49 I and C1q-SAB MFI was lowest using undiluted sera and SAB with greater than 30% denatured HLA (r = 0.
50 posure (cotinine level) in archived maternal sera and schizophrenia in offspring from a national birt
51 was also impaired for survival in guinea pig sera and sheep blood.
52 roduced particles and particles from patient sera and stool samples.
53 tudy used the Danish archived midgestational sera and their nationwide registers to search for antibo
54 easured TG level in fruit juices, beverages, sera and urine samples and reused upto 200 times over a
55 IL-6, TNF-alpha, MCP-1/CCL2 and IFN-gamma in sera, and ameliorated the organ damage of liver and kidn
56 sociated protein-like 2 (CASPR2) in maternal sera, and to relate them to subsequent psychiatric diagn
57 nsor was developed for the identification of sera antibodies (human IgG) from patients with spotted f
58           The rejection-associated miRNAs in sera appear to be ectopically expressed liver and specif
59 ence reaction, however two samples of paired sera are necessary to confirm the diagnosis, since using
60                                        Human sera are the first choice as controls for diagnostic app
61 hritis patients, C4d-PEDF complexes found in sera arise from the joints, as well as from other tissue
62              Trichinella serology on patient sera as well as polymerase chain reaction (PCR) and larv
63          Distinct miRNA levels profiled from sera at the time of clinical allograft dysfunction can b
64 nant allergens were compared in CCD-positive sera before and after inhibition with a CCD inhibitor (M
65                           Of 52 CCD-positive sera (bromelain, 1.01-59.6 kilounits of antigen per lite
66  with pathogenic IgM antibodies from patient sera but with only micromolar affinity.
67 2 protein was detected in 16 of the 40 human sera by ELISA.
68   In this study, we examined human and swine sera by swine or human TTV-specific PCRs, to determine w
69  and microarray technology, respectively, in sera collected at ages 1, 2, 3, 5, 6, 7, 10, 13, and 20
70                  Pre- and postpandemic sera (sera collected before and after isolation of the referen
71    We quantified immunological parameters in sera collected before the SM event in cases and their in
72 hypothesis, we measured the ability of human sera collected between 1979 and 2010 to block glycan bin
73                  We reviewed PRNT results of sera collected for diagnosis of ZIKAV infection from 1 J
74 agglutination-inhibition (HAI) assays, using sera collected from 382 individuals prior to the 2013-20
75             We cultured human podocytes with sera collected from DKD patients, who displayed elevated
76 rried out untargeted metabolomic analysis of sera collected from female BALB/c mice experimentally in
77 ared ADCC-mediating antibodies (ADCC-Abs) in sera collected from healthy infants, children and adults
78                                              Sera collected from patients before and during AIT with
79 ducted on 3698 swine sera, including archive sera collected in 2009, as well as samples collected in
80                                              Sera collected in 2015 showed a high prevalence of IDV a
81 tion of RSV PRNT <1:200 in one-third of cord sera confirms the need to increase levels of RSV neutral
82 rmore, levels of VEGF-D and MCP-1 in patient sera correlated positively with each other.
83 mimHNK-1)45 the inhibitory effect on patient sera could be improved by a factor of up to 230,000 per
84                      Twenty of the 53 paired sera demonstrated a >/=4-fold increase in antibody titer
85 e was changed because human, but not ferret, sera distinguish A(H1N1)pdm09 viruses isolated after 201
86                           In analyses of 500 sera, ELISA using rLb6H detected all 219 ATL samples (se
87                                     Post-AIT sera exerted IgE-blocking activity.
88                                              Sera exhibiting elevated binding without reduction after
89                  Using a set of pooled human sera exposed to OPNAs as quality control (QC) materials,
90         Stools were tested for rotavirus and sera for antirotavirus immunoglobulins by enzyme immunoa
91 dized reagents to monitor complex polyclonal sera for neutralization activity and to characterize the
92 pteronyssinus or D. farinae were assessed in sera from 1302 house dust mite (HDM)-allergic patients l
93 d metabolomic assay was performed in fasting sera from 136 CHB patients, 104 HBV-associated cirrhosis
94             Pretransplant and posttransplant sera from 162 lung recipients transplanted at 3 centers
95 -C6 antibodies were detected in pretreatment sera from 17 of 29 (59%) subjects, whereas only 5 of 29
96                                              Sera from 193 adult patients with moderate-to-severe AD
97                                              Sera from 20 subjects with moderate to severe AD, 10 sub
98 f IDV antibody titers (11.7%), while archive sera from 2009 showed statistically significant lower po
99 r binding of annexin A2 to sialostatin L2 in sera from 21 out of 23 infected patients than in sera fr
100                                 Furthermore, sera from 21 participants at three different time points
101                                              Sera from 25 highly sensitized patients were tested usin
102  broadly neutralizing antibodies (bnAbs) and sera from 30 subjects with chronic clade C infections.
103                                    We tested sera from 31,255 residents of Olmsted County, Minnesota
104                                              Sera from 35 children with proven CMA (median age at inc
105 g a custom-designed proteome microarray with sera from 35 healthy US adults revealed a continuous dis
106  processing were analyzed by immunoblot with sera from 52 peanut-allergic individuals displaying diff
107               Metabolomics-based analyses of sera from 7 patients with and 9 without T1R were conduct
108                                              Sera from 820 patients were screened on GGTA1/CMAH/B4Gal
109               Pentraxin-3 (PTX3) analyses of sera from 87 leprosy patients with or without reactions
110 ssessed by Luminex in acute and convalescent sera from 91 EM patients, in serum and synovial fluid fr
111 s compared with that of real-time PCR, using sera from a cohort of acutely infected individuals, in a
112                                  We screened sera from a cohort of Gambian children followed for six-
113                  All tests were performed on sera from a recently available, well-defined archive of
114 t H7N9 virus-infected cells were detected in sera from adults and children but not infants.
115                                              Sera from all three mouse strains enhanced HAdV-5 transd
116 rChiA was verified by immunoblot assays with sera from allergic subjects.
117 her levels of EGFL7 protein are found in the sera from AML patients than in sera from healthy control
118 actors including 3D nature of embryoid body, sera from animals, and the feeder cells isolated from mo
119 On a 7,455 peptide Pf proteome array, immune sera from at least 5 out of 9 group III vaccinees recogn
120               We then assessed rLb6H against sera from ATL patients infected with different species o
121 among these species and cultivars, mainly in sera from atopic patients that react to lupin rather tha
122                                              Sera from children and adolescents with newly diagnosed
123  IgE-immunoblotting was also conducted using sera from children with wheat allergy.
124 other but poorly with those determined using sera from children.
125 st 16 broadly neutralizing antibodies and 30 sera from chronic clade C infections.
126     Using a combination of animal models and sera from clinically well-characterized patients, we hav
127 ic activity of the formulas were tested with sera from CM-allergic patients (n = 26) in RAST-based as
128  from 21 out of 23 infected patients than in sera from control individuals was also demonstrated.
129 sed concentrations of soluble B7 compared to sera from controls.
130  effect of treatment on complement activity, sera from dosed subjects were analyzed in a CP activatio
131  and aggregated ovalbumin were measured with sera from egg-allergic children and from mice sensitized
132 d the levels of IL-6 and related proteins in sera from emphysematous mice and patients were also asse
133 od group antigen (HBGA) blocking assay using sera from GII.4 and the GII.17 variant-infected patients
134 form was constructed and immunoscreened with sera from healthy (n = 49), lung cancer (LC) (n = 31) an
135  found in the sera from AML patients than in sera from healthy controls.
136 otropic reagent Urea and probing with immune sera from healthy individuals (n = 109) increased ELISA
137 to sensitize HIV-1-infected cells to ADCC by sera from HIV-1-infected individuals.IMPORTANCE HIV-1 ev
138  eHAV produced in cell culture or present in sera from humans with acute hepatitis A.
139 ely evades polyclonal anti-AAV1 neutralizing sera from immunized mice and rhesus macaques.
140 ry products of O. viverrini and reacted with sera from infected hamsters and humans.
141 RNAs isolated from extracellular vesicles in sera from infected individuals may provide a new tool fo
142  of vaccine sera will be relative to that of sera from infected individuals.
143 e retaining its resistance to antibodies and sera from infected macaques.
144             This array was interrogated with sera from infected mice, rhesus monkeys, and humans and
145                     Pre- and postvaccination sera from kidney transplant recipients (n = 60) immunize
146 ed, because AP activity is still observed in sera from MASP-1/3-deficient Malpuech-Michels-Mingarelli
147  stimulating cellular proliferation when the sera from mice are injected sc with individual liposome-
148                                              Sera from mice immunized with a single GII.17 VLP identi
149                                              Sera from mice with acetaminophen-induced liver injury c
150 tained high levels of soluble B7 compared to sera from mice without liver injury.
151 city (ADCC) have been shown to be present in sera from most HIV-1-infected individuals.
152 was established by culturing DCs with pooled sera from multiple non-small cell lung cancer (NSCLC) pa
153  2-tier test) were equivalent in identifying sera from negative-control subjects (99% and 100% specif
154 ed viruses, we tested acute and convalescent sera from nine Thai patients with PCR-confirmed DENV inf
155    We found that treatment of podocytes with sera from normoalbuminuric type 1 diabetes patients with
156              Furthermore, using human immune sera from pandemic A/California/04/2009 immune subjects
157 y controls, cultured in the presence of both sera from patients and mtDNA, reproduced a refractory st
158 tilized to detect HM14c10-like antibodies in sera from patients who recovered from DENV-1, infection
159      Principal component analysis of data on sera from patients with AD revealed the presence of 4 po
160 more, elevated IL-16 levels are found in the sera from patients with AIH, hepatitis B virus, hepatiti
161      Plasma exchange reduces levels of B7 in sera from patients with ALF and might be used to restore
162 sion of CTLA4 after 24-48 hours culture with sera from patients with ALF; these sera were found to ha
163  pathway activation and hemolysis induced by sera from patients with atypical hemolytic uremic syndro
164            In addition, anti-SSA/Ro-positive sera from patients with connective tissue diseases showe
165  more anti-basement membrane antibodies than sera from patients with CRSwNP and control subjects (P <
166 sing quantitative proteomics of pretreatment sera from patients with grass pollen allergy reveals tha
167       Finally, assessment of AnxA1 levels in sera from patients with LCL or ML revealed that ML patie
168 tide was found using anti-SSA/Ro Ab-positive sera from patients with QTc prolongation.
169 at detecting Borrelia-specific antibodies in sera from patients with stage I LD.
170  were the most abundant antigens detected in sera from patients.
171                                              Sera from RV-positive children and adults hospitalized w
172 d aqueous pollen protein extract (APE) using sera from short ragweed pollen-sensitized patients.
173 uman CD4-Ig, SIV neutralizing antibodies, or sera from SIV-infected macaques.
174              Antigenic maps determined using sera from subjects 18-64 and >/=65 years of age correlat
175                                              Sera from subjects who received 2 doses of MF59-adjuvant
176                                              Sera from suspected ZIKV-infected patients were analyzed
177                             Also, 30 ZIKV(+) sera from symptomatic pregnant patients showed elevated
178                                              Sera from term- and preterm-born infants were also colle
179 d on a well-characterized panel of 279 human sera from the CDC, comparing ELISAs using these two reco
180 nked immunosorbent assay, we analyzed serial sera from the START study to decipher the various anti-A
181                                              Sera from two different generations of Uzbek (n=58) and,
182                                              Sera from two individuals had discordant results on the
183    A small 12-Env panel was chosen to screen sera from vaccine trials or natural-infection studies fo
184  found to improve liver glycogen storage and sera glucose level in mice expressing human AATZ mice.
185 peptides, we found that 9 of 17 (53%) paired sera had a >/=4-fold increase in antibody titer to clust
186                   In addition, animals whose sera had high capture but weak anti-infectivity activity
187 f enhanced ZIKV replication by dengue-immune sera have raised concerns about the role of previous DEN
188 r to characterize cross-reactive breadth for sera identified as having potent neutralization activity
189 evels of interleukin-15 present in patients' sera, immature NK cells (CD62L(+)NKG2A(+)KIR(-)) became
190 r was able to escape Nab activity from mouse sera immunized with parental serotypes.
191 lidated by enzyme-linked immunoassays of the sera in a certified laboratory.
192 tion of histamine in synovial fluid (SF) and sera in patients with RA was measured using ELISA.
193 rological tests were conducted on 3698 swine sera, including archive sera collected in 2009, as well
194             Chronically HCV-infected patient sera inhibited C3 convertase activity, further implicati
195 cing, the large number of cancer and control sera is required to identify cancer-specific peptides wi
196  carcinoma, whereas decline of AAT levels in sera is responsible for pulmonary emphysema.
197  human sera, IVIg, and allograft recipients' sera, it was observed that the number of HLA-Abs was not
198 gHPolyFab and FcMonoIgG against normal human sera, IVIg, and allograft recipients' sera, it was obser
199 tients with Graves' disease, but not control sera, led to secretion of TG with an increased intrinsic
200                                For undiluted sera, Luminex mean fluorescence intensity (MFI) values f
201 myosin showed IgE reactivity with 60% of the sera, lysosomal aspartic protease, and "AAEL006070-PA" (
202 e immunoreactivity of onchocerciasis patient sera (n = 152) from the Americas, West Africa, Central A
203                                              Sera (n=1131) from several clinically defined cohorts we
204                            Furthermore, such sera neutralized influenza virus, whereas this effect wa
205                                              Sera obtained from 29 healthy adults before and after pr
206 label-free mass spectrometry in pretreatment sera obtained from clinical responders and nonresponders
207                                              Sera of 1062 patients with CSU and 482 healthy control s
208                                  We examined sera of 148 children participating in the Multicentre Al
209   EBV gp350-specific IgG was detected in the sera of 17 (71%) of 24 individuals at the time of AIM an
210  and free fatty acid profiles was applied to sera of 381 individuals in 2 independent studies.
211        We investigated the clinical data and sera of 722 participants in the German Multicenter Aller
212 neutralizing antibodies were detected in the sera of all immunocompetent animals.
213 iate an allergy, such as allergic asthma, in sera of allergic subjects.
214 preferentially recognized by antibodies from sera of an MS patient subpopulation.
215 t of potentiometric determination of urea in sera of apparently healthy and persons suffering from ki
216 y quantifying anti-Neu5Gc antibody levels in sera of children enrolled in 2 farm studies: the Prevent
217 bserved from HCV-infected hepatocytes and in sera of chronic HCV patients with fibrosis compared to h
218 tion and concanavalin A binding assays using sera of cypress pollen-sensitized patients.
219                                              Sera of EDA-deficient patients contained either backgrou
220 ignificantly lower levels (P < 0.003) in the sera of HCC patients compared with healthy volunteers.
221  the formation of LVPs that circulate in the sera of HCV patients and are also produced in an in vitr
222 ification of protein and miRNA biomarkers in sera of ill children reflecting brain damage and T. gond
223 -BPA and BPA-glucuronide were quantitated in sera of individual PND 3 pups collected 1 hr postexposur
224 beta by Rickettsia-infected BMDCs and in the sera of infected mice were significantly reduced in MyD8
225  The molecule is also reactive with IgE from sera of maize-allergic subjects.
226 reased level of proinflammatory cytokines in sera of mice infected with the virus lacking the m20.1 a
227                                              Sera of mothers with a CMA infant had increased binding
228 s in vivo, was significantly elevated in the sera of newly diagnosed AML patients and is a strong ind
229                                     We found sera of patients with ALF and from mice with liver injur
230 brain extracts using autoantibodies from the sera of patients with diabetes before SDS-PAGE.
231 ulators of the serum protein patterns in the sera of patients with diffuse cutaneous systemic scleros
232 he head and neck SCCs, and EVs isolated from sera of patients with SCC were enriched in Dsg2 C-termin
233 ls of soluble MICA proteins were detected in sera of pSS patients compared to healthy controls.
234 nd levels of the complexes did not differ in sera of RA patients and healthy controls.
235  = 0.002) were significantly elevated in the sera of systemic sclerosis patients.
236                               The polyclonal sera of the three donors also reflect this preference.
237 tained and even enhanced its presence in the sera, over ten years post infection; the prevalence of o
238                                       Of 158 sera/plasma from RT-PCR-confirmed ZIKV infections, 145 (
239 ed susceptibility to neutralization by human sera pooled from approximately 60 to 80 North American d
240 er cancer associations differed by hepatitis sera-positivity in nested analyses for a subset of cases
241             The observation that prepandemic sera possess robust blocking capacity for viruses identi
242                    We found that prepandemic sera possess robust virus-blocking capacity against viru
243                     We found that 16% of the sera proteins analyzed by SOMAscan aptamer technology, f
244                                       Unique sera proteomic signatures may distinguish between inflam
245 ody competition studies revealed that immune sera raised to high-molecular-weight Delta123 was poly s
246                      By contrast, the immune sera raised to monomeric Delta123 predominantly blocked
247  epitope specificity between BM and maternal sera ranging from only 13% of sample pairs sharing at le
248                                   33% of the sera recognized a doubled band of about 14.5 kDa and thi
249 and 217 MGBs were identified from TD and ASD sera respectively, of which 74 proteins were specially i
250                Comparison of the C57 and mdx sera revealed 83 proteins with statistically significant
251                                 Some patient sera revealed IgE-binding proteins matching LTP and/or p
252           PFAAs were analyzed in 50 maternal sera samples collected in 2007-2008 from participants in
253                                   We studied sera samples from 3 groups of subjects aged >/=65 years
254                        Pre- and postpandemic sera (sera collected before and after isolation of the r
255           We observed that some CCD-positive sera show nonspecific IgE binding even with CCD-free rec
256                    Furthermore, these immune sera showed antiviral activities against a panel of gene
257                             Moreover, paired sera showed that blocking titers of >/=160 were maintain
258 ence of heterologous and autologous post-AIT sera significantly reduced the allergic airway inflammat
259 tope-specific IgA was detectable in infants' sera starting at less than 3 months of age.
260 ways were simultaneously repressed by cancer sera, suggesting that the attenuated NF-kappaB and STAT3
261 uppression withdrawal were also evaluated in sera taken at predetermined intervals during immunosuppr
262  Fc established allergen-specific artificial sera that showed comparable results for more than 20 all
263                       In contrast to pre-AIT sera, the presence of heterologous and autologous post-A
264 g them with human and/or ferret convalescent sera to human H1N1 and H3N2 viruses.
265                         While liver, but not sera, total bile acids (TBAs) were increased 75% by this
266 re was a good correlation (r = 0.99) between sera urea values obtained by reference method (Enzymic c
267 nd food allergen components were analyzed in sera using allergen microarray and compared between 5 Fr
268 frequency of some LTP isoform by our patient sera was 42%.
269        The IgE-blocking activity of post-AIT sera was assessed in vitro.
270 s reactive in 6 of 8 (75%) patients for whom sera was available.
271 Furthermore, the autoreactive capacity of CU sera was evaluated and urticaria-related symptoms were a
272            Recognition of NF54 PEs by immune sera was observed, suggesting P. falciparum erythrocyte
273 tion of the FcgammaRI reporter by survivors' sera was substantially high one year after acute infecti
274 e site-specific antibodies in vaccine immune sera, we demonstrated that vaccination elicited function
275                                          The sera were analyzed to characterize all IgG subclasses an
276                       Pre- and postinfection sera were assayed by enzyme-linked immunosorbent assay w
277                                              Sera were assessed for autoantibodies using ELISA assays
278 ins, VRC01 concentrations from participants' sera were found to avidly capture HIV virions and to med
279 ture with sera from patients with ALF; these sera were found to have increased concentrations of solu
280                                        Human sera were incubated with RBC isolated from various genet
281                                In total, 268 sera were investigated for 50% blocking titer (BT50) val
282               Pretreatment and posttreatment sera were obtained from 48 women with metastatic HER2(+)
283       Peripheral blood mononuclear cells and sera were obtained from individuals with grass pollen al
284                         In some experiments, sera were pre-incubated with alpha-gal or protein G to d
285 ere tested for ZIKV-specific antibodies, and sera were screened for other congenital infections.
286 poallergenic Cyp c 1 mutant mouse and rabbit sera were tested for their ability to inhibit IgE recogn
287                                The 17 paired sera were tested in bactericidal assays against selected
288                                              Sera were tested undiluted, at 1:20 dilution to detect h
289 e neutralization-response profile of vaccine sera will be relative to that of sera from infected indi
290   Bacterial inoculum was measured in patient sera with elevated (n = 8) or low (n = 8) IL-10 using a
291 enic maps derived from human postvaccination sera with H1 influenza preexposure also correlated poorl
292 serum Abeta42, and to be able to identify AD sera with high sensitivity.
293           Our data demonstrate that post-AIT sera with IgE-blocking activity ameliorate allergic airw
294                                          The sera with LGI1 and CASPR2 antibodies immunoprecipitated
295 so correlated poorly with those derived from sera with neither H1 nor type B influenza preexposure, a
296 wed good correlation with those derived from sera with neither H1 nor type B influenza preexposure.
297 enic maps derived from human postvaccination sera with only type B influenza preexposure consistently
298 ype H1N1 viruses, COBRA HA antigens elicited sera with the broadest HAI reactivity against multiple a
299  of an immunoglobuline preparation and three sera with unfolded CMV antigens enhanced clearly the neu
300 vitro neutralization by MV polyclonal immune sera without altering its thermostability.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top